Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition)
Top Cited Papers
- 24 April 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in World Journal of Pediatrics
- Vol. 16 (3), 232-239
- https://doi.org/10.1007/s12519-020-00362-4
Abstract
In the early February, 2020, we called up an experts’ committee with more than 30 Chinese experts from 11 national medical academic organizations to formulate the first edition of consensus statement on diagnosis, treatment and prevention of coronavirus disease 2019 (COVID-19) in children, which has been published in this journal. With accumulated experiences in the diagnosis and treatment of COVID-19 in children, we have updated the consensus statement and released the second edition recently. The current version in English is a condensed version of the second edition of consensus statement on diagnosis, treatment and prevention of COVID-19 in children. In the current version, diagnosis and treatement criteria have been optimized, and early identification of severe and critical cases is highlighted. The early warning indicators for severe pediatric cases have been summarized which is utmost important for clinical practice. This version of experts consensus will be valuable for better prevention, diagnosis and treatment of COVID-19 in children worldwide.Keywords
This publication has 14 references indexed in Scilit:
- SARS-CoV-2 Infection in ChildrenThe New England Journal of Medicine, 2020
- Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operationWorld Journal of Pediatrics, 2020
- Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trialThe Lancet Respiratory Medicine, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statementWorld Journal of Pediatrics, 2020
- Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issueWorld Journal of Pediatrics, 2020
- The antimicrobial activity of protein elicitor AMEP412 against Streptomyces scabieiWorld Journal of Microbiology and Biotechnology, 2020
- Global virus outbreaks: Interferons as 1st respondersSeminars in Immunology, 2019
- Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During InfancyScientific Reports, 2018
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational studyInternational Journal of Infectious Diseases, 2014